RA Capital Management, L.P. 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-20 4:30 pm Purchase |
2023-03-10 | 13G | Orchard Therapeutics plc ORTX |
RA Capital Management, L.P. | 18,564,300 9.990% |
18,564,300 (New Position) |
Filing |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Orchard Therapeutics plc ORTX |
RA Capital Management, L.P. | 0 0.000% |
-969,479 (Position Closed) |
Filing |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Orchard Therapeutics plc ORTX |
RA Capital Management, L.P. | 969,479 7.700% |
-262,042 (-21.28%) |
Filing |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Orchard Therapeutics plc ORTX |
RA Capital Management, L.P. | 1,231,521 12.600% |
195,056 (+18.82%) |
Filing |